OLIGONUCLEOTIDE BASED THERAPEUTICS Treatment of genetic neuromuscular diseases by using its tricyclo-DNA molecular technology CONTACT Synthena AG Holderstrasse 5, 3011 BERN Switzerland Mail info@synthena.com
